Skip to content
10-K

Annual Report

SpyGlass Pharma, Inc. SGP

0001778922-26-000020

← back to feed
Filed
Mar 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 1, 2026 33.43M sh
Shares Diluted FY 2025 · Dec 31, 2025 2.22M sh
Shares Diluted FY 2025 · Dec 31, 2024 1.79M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $1.45M
Stock Repurchased FY 2025 · Dec 31, 2024 $0
Capex FY 2025 · Dec 31, 2025 $789K
Capex FY 2025 · Dec 31, 2024 $1.99M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$32.7M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$22.03M
Cash And Equivalents FY 2025 · Dec 31, 2025 $96.36M
Cash And Equivalents FY 2025 · Dec 31, 2024 $16.27M
Stockholders Equity FY 2025 · Dec 31, 2025 −$98.84M
Stockholders Equity FY 2025 · Dec 31, 2024 −$60.47M
Stockholders Equity FY 2025 · Dec 31, 2023 −$32.99M
Current Liabilities FY 2025 · Dec 31, 2025 $8.58M
Current Liabilities FY 2025 · Dec 31, 2024 $7.79M
Total Liabilities FY 2025 · Dec 31, 2025 $10.17M
Total Liabilities FY 2025 · Dec 31, 2024 $11.25M
Current Assets FY 2025 · Dec 31, 2025 $108.77M
Current Assets FY 2025 · Dec 31, 2024 $17.41M
Total Assets FY 2025 · Dec 31, 2025 $115.87M
Total Assets FY 2025 · Dec 31, 2024 $23.32M
Eps Diluted FY 2025 · Dec 31, 2025 −$17.98
Eps Diluted FY 2025 · Dec 31, 2024 −$16.31
Eps Basic FY 2025 · Dec 31, 2025 −$17.98
Eps Basic FY 2025 · Dec 31, 2024 −$16.31
Sga Expense FY 2025 · Dec 31, 2025 $12.27M
Sga Expense FY 2025 · Dec 31, 2024 $7.08M
Rd Expense FY 2025 · Dec 31, 2025 $29.18M
Rd Expense FY 2025 · Dec 31, 2024 $19.98M
Net Income FY 2025 · Dec 31, 2025 −$39.87M
Net Income FY 2025 · Dec 31, 2024 −$29.16M
Operating Income FY 2025 · Dec 31, 2025 −$41.45M
Operating Income FY 2025 · Dec 31, 2024 −$27.06M